BrightNight, a leading next-generation power and digital infrastructure company, together with its joint venture partner, Cordelio Power, announced reaching financial close for Pioneer Clean Energy ...
Use of GLP-1 receptor agonists was associated with a twofold higher risk for neovascular age-related macular degeneration development in a population-based study published in JAMA Ophthalmology. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback